Literature DB >> 19475679

The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?

Ester Vanni, Elisabetta Bugianesi.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19475679     DOI： 10.1002/hep.23036

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis.

Authors:  Laura A Navarro; Alexander Wree; Davide Povero; Michael P Berk; Akiko Eguchi; Sudakshina Ghosh; Bettina G Papouchado; Serpil C Erzurum; Ariel E Feldstein
Journal:  J Hepatol       Date:  2014-09-16       Impact factor: 25.083

Review 2.  Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

Authors:  Ekihiro Seki; Bernd Schnabl
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

Review 3.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population.

Authors:  Hui-Qi Qu; Quan Li; Megan L Grove; Yang Lu; Jen-Jung Pan; Anne R Rentfro; Perry E Bickel; Michael B Fallon; Craig L Hanis; Eric Boerwinkle; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Arch Med Res       Date:  2012-09-05       Impact factor: 2.235

Review 6.  Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Yan-Yan Ma; Lin Li; Chao-Hui Yu; Zhe Shen; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

7.  The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning.

Authors:  Hui-Qi Qu; Quan Li; Anne R Rentfro; Susan P Fisher-Hoch; Joseph B McCormick
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

Review 8.  Molecular Pathogenesis of NASH.

Authors:  Alessandra Caligiuri; Alessandra Gentilini; Fabio Marra
Journal:  Int J Mol Sci       Date:  2016-09-20       Impact factor: 5.923

9.  Ablation of Hmgb1 in Intestinal Epithelial Cells Causes Intestinal Lipid Accumulation and Reduces NASH in Mice.

Authors:  Harriet Gaskell; Xiaodong Ge; Romain Desert; Sukanta Das; Hui Han; Daniel Lantvit; Grace Guzman; Natalia Nieto
Journal:  Hepatol Commun       Date:  2019-11-12

Review 10.  Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology.

Authors:  Xiao-Fang Yang; Ming Lu; Lijiao You; Huan Gen; Lin Yuan; Tianning Tian; Chun-Yu Li; Kailiang Xu; Jie Hou; Ming Lei
Journal:  Chin Med       Date:  2021-07-27       Impact factor: 5.455
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.